IASIS PHARMA PARTICIPATION IN THE 21st PANHELLENIC DIABETES CONGRESS
Divani Caravel Hotel, Athens, 8-11/03/2023 IASIS PHARMA participated in the 21st National Diabetes Congress, showing its active interest in Diabetes Mellitus disease, promoting cornerstone pharmaceutical products for type 2 diabetes. Moreover, IASIS PHARMA is about to invest significantly in T2DM in the near future, launching more than 4 original products. The conference took place on [...]